Baxter and Kamada in GLASSIA Deal

August 24, 2010

Medical product giant Baxter International Inc. has entered into a definitive distribution agreement with Israel-based biopharmaceuticals company Kamada Ltd. Under the deal, it has secured exclusive marketing rights to Kamada's GLASSIA Alpha 1-Proteinase inhibitor in the U.S., Canada, Australia and New Zealand.

Click here to read full article.

Quick Links

Dotted Line

Top Cities

Dotted Line

By filling out our free case evaluation form, you are NOT forming an attorney-client relationship. You can only retain an attorney by entering into a fee agreement; by submitting our form you are not entering into a fee agreement. Our form is not a request for legal advice. Any information that you will receive in response to your questions is general information and you will NOT be charged for it. THIS IS AN ADVERTISEMENT. The attorneys listed on and within the Accidents.com webpages have paid an advertisement fee to Accidents.com. The attorney pages shall not be considered an endorsement of an attorney or referral to an attorney by the Accidents.com service. Your use of this site is subject to additional Terms & Conditions.

Accidents.com is the fastest growing community of accident attorneys, medical and safety professionals working to minimize the impact accidents have on our lives. Learn more.

All content on Accidents.com is for informational purposes only and is NOT intended as legal or medical advice. Please seek advice from a professional on any related topics.

Thursday, February 9, 2012
Copyright © 2012, Brightgeist Media, Inc.